Kampf D, Höfer W, Misgeld V, Alexander M
Immun Infekt. 1979 Aug;7(4):121-8.
Since 1970 in 27 out of 46 patients with the diagnosis of systemic lupus erythematosus (SLE) a renal biopsy could be taken. The morphological outcome was followed in 14 patients with a total of 18 repeated biopsies. By light- and electron microscopy renal involvement was demonstrable in all patients. Four histologic subgroups could be differentiated: Mesangio-proliferative (MESLN, 14), focal proliferative (FLN, 6), diffus proliferative (DLN, 6), and membranous lupus nephritis (MLN, 1). Some biopsies demonstrated linear deposits with IgG/IgA-specificity. 2/27 patients only showed a clinical deteriorating course with progressive renal insufficiency despite steroid or steroid-azathioprine therapy. One patient with DLN died in terminal renal failure. The morphological follow-up showed an unfavourable course in 3/14 patients only. One MESLN demonstrated a transition to DLN, one DLN an increase of proliferative lesions and a second DLN focal and local sclerosis. In our experience renal involvement in SLE can adequately characterised and controlled by repeated be clinico-pathological correlations an aggressive therapeutic regimen is not indicated and can be avoided.
自1970年起,46例诊断为系统性红斑狼疮(SLE)的患者中有27例接受了肾活检。对14例患者进行了形态学随访,共进行了18次重复活检。通过光镜和电镜检查,所有患者均显示有肾脏受累。可区分出四个组织学亚组:系膜增生性(MESLN,14例)、局灶增生性(FLN,6例)、弥漫增生性(DLN,6例)和膜性狼疮肾炎(MLN,1例)。一些活检显示有IgG/IgA特异性的线性沉积物。27例患者中有2例尽管接受了类固醇或类固醇-硫唑嘌呤治疗,但仍表现出临床病情恶化及进行性肾功能不全。1例DLN患者死于终末期肾衰竭。形态学随访仅显示14例患者中有3例病情进展不利。1例MESLN转变为DLN,1例DLN增生性病变增加,另1例DLN出现局灶性和局部硬化。根据我们的经验,通过反复进行临床病理相关性分析,SLE的肾脏受累情况可得到充分的特征描述和控制,无需采用积极的治疗方案,且可避免。